Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Gee

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Cytotherapy|April 30, 2010
Product release assaysA P Gee
Cancer Gene Therapy|January 31, 2015
Manufacturing genetically modified T cells for clinical trialsA P Gee
Cancer Investigation|January 1, 1987
Low antigen density tumor cells: an obstacle to effective autologous bone marrow purging?M D Boyle, A P Gee
Journal of the National Cancer Institute|April 6, 1988
Purging tumor cells from bone marrow by use of antibody and complement: a critical appraisalA P Gee, M D Boyle
Cytotherapy|April 16, 2002
Cell sorting for therapeutic applications - points to considerA P Gee, A G Durett
Analytical Biochemistry|September 15, 1981
Immunoassay using 125I- or enzyme-labeled protein A and antigen-coated tubesA P Gee, J J Langone
Cytotherapy|July 10, 2003
Gene transfer: regulatory issues and their impact on the clinical investigator and the good manufacturing production facilityB J Grilley, A P Gee
Journal of Hematotherapy|January 1, 1993
ISHAGE grows up. International Society for Hematotherapy and Graft EngineeringA P Gee, N H Collins
Cytotherapy|September 15, 2009
ISHAGE committees--the whole is, indeed, and in deed, greater than the sum of its partsN H Collins, A P Gee
American Journal of Hematology|July 1, 1984
Migration of porcine endothelial and smooth muscle cells in response to platelet-associated factorsA P Gee, J O Minta
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Cytotherapy|April 30, 2010
Product release assaysA P Gee
Cancer Gene Therapy|January 31, 2015
Manufacturing genetically modified T cells for clinical trialsA P Gee
Cancer Investigation|January 1, 1987
Low antigen density tumor cells: an obstacle to effective autologous bone marrow purging?M D Boyle, A P Gee
Journal of the National Cancer Institute|April 6, 1988
Purging tumor cells from bone marrow by use of antibody and complement: a critical appraisalA P Gee, M D Boyle
Cytotherapy|April 16, 2002
Cell sorting for therapeutic applications - points to considerA P Gee, A G Durett
Analytical Biochemistry|September 15, 1981
Immunoassay using 125I- or enzyme-labeled protein A and antigen-coated tubesA P Gee, J J Langone
Cytotherapy|July 10, 2003
Gene transfer: regulatory issues and their impact on the clinical investigator and the good manufacturing production facilityB J Grilley, A P Gee
Journal of Hematotherapy|January 1, 1993
ISHAGE grows up. International Society for Hematotherapy and Graft EngineeringA P Gee, N H Collins
Cytotherapy|September 15, 2009
ISHAGE committees--the whole is, indeed, and in deed, greater than the sum of its partsN H Collins, A P Gee
American Journal of Hematology|July 1, 1984
Migration of porcine endothelial and smooth muscle cells in response to platelet-associated factorsA P Gee, J O Minta
Pageof 8